314 related articles for article (PubMed ID: 31047294)
1. Genome Editing in Retinal Diseases using CRISPR Technology.
Yiu G
Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
[No Abstract] [Full Text] [Related]
2. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
Lin WV; Stout JT; Weng CY
Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
[No Abstract] [Full Text] [Related]
3. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
4. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
Sanjurjo-Soriano C; Kalatzis V
Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
[TBL] [Abstract][Full Text] [Related]
5. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
6. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC; Musunuru K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
[TBL] [Abstract][Full Text] [Related]
8. More specific CRISPR editing.
de Souza N
Nat Methods; 2014 Jul; 11(7):712. PubMed ID: 25110782
[No Abstract] [Full Text] [Related]
9. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
10. CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.
Cho GY; Schaefer KA; Bassuk AG; Tsang SH; Mahajan VB
Retina; 2018 Aug; 38(8):1443-1455. PubMed ID: 29746416
[TBL] [Abstract][Full Text] [Related]
11. The Implications of CRISPR-Cas9 Genome Editing for IR.
Perkons NR; Sheth R; Ackerman D; Chen J; Saleh K; Hunt SJ; Nadolski GJ; Shi J; Gade TP
J Vasc Interv Radiol; 2018 Sep; 29(9):1264-1267.e1. PubMed ID: 30146193
[No Abstract] [Full Text] [Related]
12. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
Musunuru K
J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
[TBL] [Abstract][Full Text] [Related]
13. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
Wang W; Hou J; Zheng N; Wang X; Zhang J
Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
[No Abstract] [Full Text] [Related]
14. Could CRISPR be the solution for gene editing's Gordian knot?
Fang H; Wang W
Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448
[No Abstract] [Full Text] [Related]
15. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
16. Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.
Chrenek MA; Nickerson JM; Boatright JH
Asia Pac J Ophthalmol (Phila); 2016; 5(4):304-8. PubMed ID: 27488072
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 genome surgery for retinal diseases.
Xu CL; Park KS; Tsang SH
Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
[TBL] [Abstract][Full Text] [Related]
18. The promise and peril of CRISPR gene drives: Genetic variation and inbreeding may impede the propagation of gene drives based on the CRISPR genome editing technology.
Zentner GE; Wade MJ
Bioessays; 2017 Oct; 39(10):. PubMed ID: 28863233
[TBL] [Abstract][Full Text] [Related]
19. Genome Surgery and Gene Therapy in Retinal Disorders.
Chan L; Mahajan VB; Tsang SH
Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
[TBL] [Abstract][Full Text] [Related]
20. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]